Back to Search
ALAN HOUGHTON, M.D.
M.D.
Medical Oncology Physician
NPI: 1396893392Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
140772-1(NY)018173(CT)
Research & Publications (20)
The role of the immune system in early epithelial carcinogenesis: B-ware the double-edged sword.
PMID 15894259·Cancer Cell·2005
7-preclinical
Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake rats.
PMID 11275375·Pain·2001
7-preclinical
Epithelial cell apoptosis causes acute lung injury masquerading as emphysema.
PMID 19188661·Am J Respir Cell Mol Biol·2009
4-observational
Patency of infra-inguinal vein grafts--effect of intraoperative Doppler assessment and a graft surveillance program.
PMID 19497506·J Vasc Surg·2009
8-other
Addressing climate change and local public health: the Austin Climate Protection Program and the CDC Working Group on Climate Change collaboration.
PMID 19408428·J Environ Health·2009
8-other
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.
PMID 19332877·J Exp Med·2009
7-preclinical
Development of effective vaccines for old mice in a tumor model.
PMID 19103244·Vaccine·2009
7-preclinical
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.
PMID 19011222·Blood·2009
7-preclinical
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.
PMID 19496531·Cancer Immun·2009
3-trial
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.
PMID 19414558·J Exp Med·2009
7-preclinical
Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
PMID 19047169·Cancer Res·2008
7-preclinical
Selective expression of inhibitory Fcgamma receptor by metastatic melanoma impairs tumor susceptibility to IgG-dependent cellular response.
PMID 18798552·Int J Cancer·2008
7-preclinical
Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.
PMID 18797450·Mol Ther·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (646) 888-2315
Quick Facts
- NPI
- 1396893392
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile